Drugs / REFRESH OPTIVE UD
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT07284381 Comparator | Dec 2025 → Aug 2026 overdue | dry eye syndrome | AbbVie | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | REFRESH OPTIVE UD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07284381 ↗ |
| Route | Topical | “Topical eye drop” NCT07284381 ↗ |